FDA Approved: LACTULOSE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approves Lactulose from Chartwell RX, LLC under ANDA209517; a generic formulation indicated for constipation and hepatic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Hepatic Encephalopathy

Drugs mentioned

• LACTULOSE (Lactulose)

Snippet

ORIG AP for LACTULOSE (LACTULOSE)